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Work during the past several years has produced new insights
into many aspects of the cell biology of ischemic injury to the
tubulointerstitium. The major processes are conveniently con-
sidered in terms of early events, the prelethal and lethal cell
injuries that occur during the period of ischemia and in the first
hours of reperfusion, and late events, the proliferation and
fibrosis which repair and restructure the damaged tissue. Most
currently available data are pertinent to understanding the early
events at the tubule cell level, and this information will neces-
sarily comprise most of the review.
In considering the cell biology of ischemic injury and models
for its study, the relationships between ischemia, hypoxia,
anoxia and 'chemical anoxia' must be kept in mind. Ischemia
involves cessation of circulation to a tissue so that metabolic
substrates are not delivered and metabolic products are not
removed. In the kidney, as in most tissues, ischemia will
generally be accompanied by severe oxygen deprivation, al-
though effects of surface oxygenation in systems which are not
completely sealed and collateral flow can complicate this [1, 21.
Hypoxia indicates a state in which oxygenation is reduced
below the critical p02, the level of oxygen required for com-
plete oxidation of cytochrome C. This value for proximal
tubules is 10 to 17 mm Hg [3—51. Gradients of oxygenation
which determine degrees of hypoxia are commonly observed
both within tissues, as delineated in recent studies of perfusion
and hypoxic injury to the outer medulla [6—8], and within
individual cells [31. Anoxia indicates complete absence of
oxygen, a condition which should be verified by documentation
that mitochondrial cytochromes are fully reduced [3, 5, 9].
'Chemical anoxia' involves use of metabolic inhibitors to
induce the severe ATP depletion characteristic of ischemia and
other oxygen deprivation states. It always requires an inhibitor
of mitochondrial ATP production and, in cells with substantial
glycolytic capacity, a maneuver to inhibit glycolysis such as
glucose removal, competition with glucose by deoxyglucose, or
an enzyme inhibitor. 'Chemical anoxia' allows for studies of
some of the major consequences of ATP depletion such as that
produced by ischemia under conditions where anoxia or hy-
poxia are not feasible or desirable, and provides complete
control over the timing of inhibitory effects. Use of metabolic
inhibitors is complicated by the potential for actions at cellular
sites in addition to the primary target. For example, cyanide
inhibits catalase [101 as well as cytochrome C oxidase, its
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intended target in studies of chemical hypoxia. Iodoacetate is
valuable for inhibiting glycolysis via its actions on glyceralde-
hyde-3-phosphate dehydrogenase, but its high general reactiv-
ity with sulfhydryl groups results in effects on other proteins
and glutathione [11]. Doing parallel studies with several chem-
ically unrelated agents, that act to inhibit energy metabolism via
different mechanisms, is a useful approach for separating agent-
specific effects that may not be generally applicable to under-
standing ischemic injury from actions commonly mediated by
ATP deletion and relevant to ischemic injury. The presence of
02 during 'chemical anoxia' may emphasize reactive oxygen
metabolite-mediated mechanisms of injury that would not be
expressed during oxygen deprivation states [12—15]. Oxygen
deprivation, itself, may initially evoke protective membrane
alterations that would not occur during 'chemical anoxia'
[15—181. These issues must be considered in the interpretation
of data from 'chemical anoxia' models, but they do not preclude
the usefulness of these models.
Although the ultimate goal in studying ischemic injury is to
understand and, possibly, ameliorate a ubiquitous in vivo
phenomenon, work with in vivo models faces obstacles in
defining pathogenetic events at the cellular level because of the
complexity of dealing with all relevant tissue compartments
simultaneously, the many possible reciprocal interactions be-
tween cellular, nephronal and hemodynamic processes, and the
difficulty accessing sites of injury for various measurements. As
in virtually all other areas of cell biology, this has led to
increasing use of isolated cell systems for studies of pathophys-
iology.
Both the isolated perfused kidney and freshly isolated tubules
allow direct experimental manipulation of fully differentiated,
mature tubule cells. The isolated perfused kidney preserves the
structural arrangements of the in vivo state, does not subject
cells to damage resulting from tissue dissociation, allows infor-
mation to be obtained about multiple tubule segments, and can
provide information about the vascular compartment, but suf-
fers from some of the same access problems intrinsic to studies
done in vivo. Freshly isolated tubule preparations bring greater,
but not complete, specificity to the tubule segment studied and
can be used both in suspension and as single tubules for
virtually all measurements of pathogenetic processes and ex-
perimental manipulations pertinent to understanding the cell
biology of injury. However, there is a certain amount of
background damage induced by the isolation and studies are
limited to several hours.
Cultured tubule cells provide the advantages of freshly iso-
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lated tubules with regard to accessibility for measurements and
manipulations, and have the additional major advantage of
permitting studies over days, thus allowing a more complete
assessment of repair and proliferative events than freshly
isolated tubules. However, survival in culture conditions neces-
sitates changes of intrinsic tubule susceptibility to oxygen
deprivation which can alter the relative importance of various
pathogenetic events. Thus, cultured cell systems are not ideal
for initially establishing the occurrence or relevance of a
pathophysiologic process. However, once processes are known
to occur similarly in cultured cells and in more differentiated
systems, the cultured cells can be very valuable for assessing
mechanistic issues.
Isolated cell and tissue systems studied in vitro never com-
pletely duplicate the environment of the kidney in vivo and can
omit factors of importance, but are also valuable for elucidating
them. For example, the influence of marginal states of oxygen-
ation relative to workload in specific nephron segments was
clarified as a result of attempts to understand and correct a
deficiency of the isolated kidney preparation [6, 19, 201. The
major effects of reduced pH and the small amino acids, glycine
and alanine, to modulate tubule response to injury were largely
recognized because these factors were absent in simple systems
for studying isolated tubules in suspension [21—231. Once such
effects are identified, they can be studied in vitro under condi-
tions which allow their maximal expression to allow assessment
of mechanisms as well as under conditions likely to simulate
their contributions to the injury which occurs in vivo.
Cell death, the most severe and significant outcome of
ischemic injury, can be manifested in several ways depending
on the cell type and the lesion. It is most evident when the cell
undergoes a progressive series of disorganizing, morphologic
alterations ending in its complete disintegration [24—27]. Al-
though exceptions have been described under special condi-
tions [281, the type of plasma membrane damage which permits
leakage of large cytosolic molecules such as lactate dehydroge-
nase and nuclear staining with normally impermeant dyes such
as Trypan blue, nigrosin, or propidium iodide identifies cells
which have sustained the type of damage which will not be
reversible, even if injurious conditions such as oxygen depriva-
tion or a metabolic inhibitor are removed [28—301. Severe
decreases of ATP and loss of intracellular K under conditions
which prevent ATP synthesis and function of Na,K-ATPase do
not necessarily imply lethal cell injury, since they can clearly be
reversed [21, 28, 31]. However, failure of these parameters to
recover once conditions preventing ATP synthesis and pump
function are removed, can be another indicator of lethal cell
damage. Cell death may also be defined as loss of capability to
proliferate. Cellular disintegration will obviously result in this,
however, failure of proliferation could also occur as a result of
selective damage to nucleic acids and their regulatory compo-
nents in cells which have maintained or recovered plasma
membrane integrity and ATP-generating capacity. Such injury
is of particular relevance to toxic, radiation, and oxidant insults
and it has been argued, on this basis, that proliferation assays
are the safest criteria for cell death [31]. However, proliferation
assays are not readily applicable to systems where acute injury
to fully differentiated tubule cells is the major process, and
virtually all the data reviewed here indicate that reasonable
conclusions can be drawn about ischemic lethal cell injury in
the kidney by using the standard criteria of enzyme release and
vital dye exclusion.
As detailed in sections which follow, a number of end points
short of cell death can also have serious consequences for tissue
function. These include loss of viable cells from the epithelial
surface creating discontinuities which result in backleak, de-
creases of surface area and energy generating components
resulting in decreased transport capacity, and loss of normal
polarity.
Much debate has centered around whether a particular sub-
cellular organelle or membrane is the most important site of
damage which determines the transition to lethal cell injury.
Mitochondria, lysosomes and the plasma membrane have re-
ceived major attention [26, 32—34]. However, most of the major
biochemical events have impact on more than a single organelle
or membrane, and recent data are most effectively categorized
and reviewed according to the biochemical processes involved.
Pathophysiologic events during acute ischemic cell damage
Alterations of purine nucleotide metabolism
Failure of cells to maintain ATP levels is the hallmark of
ischemia [35—39] and underlies most of the changes in cellular
cation balance and metabolism which characterize that state.
Oxygen deprivation most directly limits mitochondrial ATP
production, although subsequent changes of cell pH can ulti-
mately reduce glycolysis as well [40]. Thus, cells with the
greatest dependence on mitochondrial ATP production, such as
the proximal tubule [41, 42], will generally be more susceptible
to oxygen deprivation-induced ATP depletion, although intrin-
sic structural factors also clearly have a major role. This is well
illustrated by measurements of ATP and related metabolites in
rat nephron segments dissected following brief periods of
ischemia, where proximal convoluted and proximal straight
tubules had much greater ATP depletion than distal convoluted
tubule or thick ascending limb [43]. It is also evident in the
different propensities to oxygen deprivation-induced ATP de-
pletion and injury of nephron segments in vivo and freshly
isolated tubules on the one hand and cultured tubule cells on the
other. Cultured tubule cells, even primary cultures, tend to be
highly glycolytic and are much more resistant to oxygen depri-
vation, and metabolic inhibitor-induced AlP depletion and cell
injury [44, 45].
In vivo, regional differences of perfusion and workload
interact with intrinsic tubule metabolic characteristics to deter-
mine susceptibility to ATP depletion. Thus, S3 segments appear
to have the higher glycolytic capacity than the other proximal
tubule segments [42, 46—49], but are the most prominent sites of
injury during common experimental models of ischemic acute
renal failure [24, 25, 27, 50—52]. Similarly, the medullary thick
ascending limb has a substantial glycolytic capacity [41, 43], yet
is highly susceptible to oxygen deprivation injury [53]. Both
these nephron segments are found in the outer medulla, where
oxygenation appears to be marginal, even in normally perfused
kidneys, due to metabolic demands and effects of countercur-
rent exchange to shunt 02 [6, 7, 19, 54, 55]. Additionally,
significant 02 gradients are present even within tubule cells
because of asymmetric localization of mitochondria [3].
The role of abnormal mitochondrial function as a primary
contributor to cell damage differs during ischemia and reoxy-
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genation. During ischemia, mitochondrial oxidative phosphor-
ylation is suppressed by lack of oxygen and intrinsic membrane
alterations that may, in fact, be structurally protective for a
period of time [17, 18, 56—591. A characteristic progression of
mitochondrial morphologic alterations has been described [26].
Initial condensation of the mitochondrial matrix and dilatation
of the inter-cristaë spaces is followed by moderate swelling.
These changes are reversible. Longer durations of ischemia
result in large amplitude swelling, fragmentation of cristae and
formation within the matrix of flocculent densities containing
protein and lipid [60]. Reperfusion of tissue with these mito-
chondrial alterations produces matrix granular densities con-
sisting of calcium phosphate [26, 60]. A main question has been
whether persistent or newly developed mitochondrial func-
tional deficits in reversibly injured cells contribute to cell
damage later during reoxygenation [35, 56, 61, 62], and whether
functional changes of mitochondria isolated at that time repre-
sent pathophysiologically important alterations of mitochondria
from potentially viable cells or only post-lethal changes secOnd-
ary to calcium overload and other damaging processes which
follow loss of plasma membrane barrier function [33, 57, 58].
The latter process is favored by a variety of observations
consistent with rapid and virtually complete recovery of mito-
chondrial function after ischemia or hypoxia so long as plasma
membrane integrity is preserved [9, 21, 57, 58].
Possibilities for enhancing anaerobic ATP production during
ischemia by glycolysis and at the mitochondrial level have been
explored. ATP production by anaerobic mitochondrial oxida-
tion of a-ketoglutarate to succinate or reduction of fumarate to
succinate have been described in the kidney and have been
reported to provide support for renal function during hypoxia in
the isolated perfused kidney 1631. However, the response of
isolated rabbit tubules to hypoxia did not appear to be substan-
tially altered by provision of a-ketoglutarate [23, 64]. Attempts
to enhance glycolytic ATP production and thereby improve
resistance of isolated proximal tubules to hypoxia were not
successful 123].
It has been noted that the apparent ability to recover cell ATP
after ischemia is more closely associated with the occurrence of
lethal cell injury than severity of ATP depletion during ischemia
[36, 65, 66], leading to the suggestion that absence of ATP may
not be the central mediator of ischemic injury [67]. This
argument, however, does not take into account the role of
relatively small changes of ATP at low ATP levels in promoting
damage and the cumulative effects over time of ATP depletion.
A recent study of metabolic inhibitor-induced injury to cultured
tubule epithelial cells has emphasized the importance, at low
cell ATP levels, of relatively small differences of cell ATP in
determining whether cell viability is maintained [44]. Although
multiple factors which can modify damage produced by similar
degrees of ATP depletion are described in this review, virtually
all the data favor ATP depletion as the process initiating the
events necessary for ischemic cell injury and degree of ATP
depletion as a major determinant of the severity of injury.
Purine metabolism during ischemia has received substantial
attention during the past several years with regard to: 1)
definition of the pathways for nucleotide degradation and the
possibilities for manipulating these pathways to improve cell
ATP during oxygen deprivation and reoxygenation; and 2) the
role of purine metabolites as substrates for generation of
reactive oxygen species metabolites during ischemia and reox-
ygenation.
Failure of the mitochondrial and glycolytic mechanisms for
phosphorylation of ADP to ATP leads to the accumulation of
AMP because myokinase converts available ADP to AMP and
ATP until the ADP is exhausted [68]. The two specific pathways
for catabolism of AMP are conversion by AMP deaminase to
IMP or by 5'-nucleotidase to adenosine. 5'-nucleotidase has
both plasma membrane and cytosolic forms subject to differing
regulation in various tissues. In the rat kidney, the membrane
bound form is inhibited by ATP, ADP, the nucleotide analog,
a,f3-methylene adenosine-5'-diphosphate (AMPCP), and by
theophylline [69], and has been localized by histochemistry to
the proximal tubule brush border membrane and interstitial
fibroblasts [69, 70]. f3-glycerol phosphate, but not AMPCP,
inhibited the degradation of medium AMP by isolated rabbit
proximal tubules, suggesting a more prominent role for non-
specific surface phosphatases in AMP catabolism by tubules
from that species [71]. The rat cytosolic 5'-nucleotidase had a
km of 9.5 LM for AMP which was increased at physiological
levels of ATP (km of 259 M at 5 mM ATP). The enzyme was
also strongly inhibited as the pH decreased from 7.6 to 6.4, the
same range in which pH varies during ischemia [72, 73].
Although the decrease in ATP during ischemia would serve to
activate 5'-nucleotidase, the main regulatory effect during
ischemia would likely be inhibition of activity as a result of
decreased pH, because the millimolar concentrations of AMP
initially produced during ischemia 121, 36, 38] are well in excess
of the km at even low ATP levels. AMP deaminase is present in
the kidney [71, 74], but the small amounts of IMP detected
during oxygen deprivation and purine loading [71, 75] suggest
relatively low levels of activity in that setting.
Adenosine and IMP are readily reconverted to ATP. Inosine,
their common breakdown product, must be further metabolized
to hypoxanthine before it can be salvaged by hypoxanthine
guanine phosphoribosyltransferase. The products of hypoxan-
thine metabolism, xanthine and uric acid, are not salvageable
for reentry into the purine pool [76].
Recent studies have shown that not all these pathways are
necessarily available and species differences exist. AMP deam-
inase and 5'-nucleotidase have been discussed previously.
Purine catabolism by ischemic rabbit kidney and isolated rabbit
proximal tubules does not proceed beyond hypoxanthine [71,
77—79], indicating little or no xanthine oxidase activity. Rat
kidneys, on the other hand, produces significant amounts of
uric acid during ischemia-induced purine degradation [80—82].
Adenosine is readily salvaged via adenosine kinase for incor-
poration into cellular ATP by normally oxygenated rabbit
tubule cells capable of generating the ATP for adenosine kinase;
however, inosine and hypoxanthine are not reutilized irrespec-
tive of the presence of allopurinol and its metabolite, oxypuri-
nol [71, 77, 79, 831. In contrast, in the rat, oxypurinol and
hypoxanthine infusion in vivo each enhanced recovery of tissue
ATP following ischemia [821. These metabolic considerations
are not simply curiosities of experimental systems. Invoking
pathways, such as salvage of purine nucleosides or metabolism
by xanthine oxidase, with production of reactive oxygen metab-
olites as central events in ischemic injury and recovery requires
their availability within or in close proximity to the target cells
of interest.
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Studies of both ischemic acute renal failure in vivo [36, 75,
84, 85] and oxygen deprivation injury to isolated tubules [77]
have shown that the predominant recovery of cell ATP during
reoxygenation is from intracellular AMP. Recovery from nude-
osides and bases, as detailed above, is limited by the availability
of salvage pathways, and is energetically less favorable since it
requires ATP at a time when the pool is diminished. De novo
synthesis is yet more complex and energetically unfavorable
[76]. Nucleosides and bases have also been considered to be
more membrane permeable due to well defined mechanisms for
their membrane transport [871 and, therefore, prone to washout
with reperfusion [88—90]. Catabolism to nucleosides and bases
by surface enzymes also occurs due to AMP leakage from cells
with advanced injury. The relative importance on intracellular
and extracellular breakdown is not known.
Reports of beneficial effects of nucleoside infusion during
ischemic acute renal failure [91] and the finding of protection by
MgATP infusion [85, 92—95] have led to further studies on ways
to ameliorate the depletion of the cellular purine pool during
oxygen deprivation and promote recovery of ATP during reox-
ygenation via administration of exogenous purines and maneu-
vers to interrupt purine degradation. Isolated rabbit proximal
tubules are capable of substantially increasing their ATP levels
when provided with exogenous nucleotides or adenosine [71,
79, 83]. Although nucleotides appear to be more effective than
adenosine [71, 79, 83] and direct uptake of nucleotides has been
proposed [96—97], most data favor the notion that the effects of
exogenous adenine nucleotides on the cellular nucleotide pool
are mediated entirely by adenosine uptake. Adenosine appears
to be less effective than nucleotides because, at high concen-
trations, adenosine inhibits adenosine kinase, slowing its con-
version to AMP intracellularly. Degradation of nucleotides to
adenosine allows adenosine delivery without immediately intro-
ducing a maximal concentration of adenosine [71]. This aug-
mentation of cellular ATP requires ATP for phosphorylation of
adenosine by adenosine kinase and, thus, only occurs in oxy-
genated, normally metabolizing cells [71, 79, 83]. Similar in-
creases of tissue ATP have been reported after adenosine
infusion in vivo [99] and in isolated perfused rat kidneys treated
with MgATP or adenosine [100]. Work using tissue preserva-
tion models is also consistent with the potential for augmenting
tubule cell nucleotide levels by supplementation with adenosine
[10 1—103]. Effects of exogenous adenosine on cell ATP levels
are not necessarily limited to the tubule epithelium since they
have been reported for endothelial cells [104] and fibroblasts
[105].
The amelioration of ischemic acute renal failure by systemic
infusion of MgATP is associated with accelerated recovery of
ATP levels [851. Both amelioration of injury and enhanced
recovery of ATP levels are also seen with ADP and AMP
infusion, so that provision of precursors for recovery of the
cellular purine pool appears to be involved [85, 106]. In fact, the
relative effects of systemically administered adenosine and
nucleotides on renal ATP levels and their patterns of catabolism
are very similar to the relationships defined with the isolated
tubule systems in that nucleotide administration sustains circu-
lating levels of adenosine better than administration of adeno-
sine itself [107], and an inhibitor of adenosine uptake, nitroben-
zylthioinosine (NBTI), prevented the enhancement of tissue
ATP levels produced by postischemic nucleotide infusion [108].
NBTI did not improve tissue ATP levels in the absence of
exogenous nucleotide treatment [108], and brief, intermittent
reperfusion during ischemia with washout of purine metabolites
did not impair postischemic recovery of ATP [89], suggesting
that salvage does not contribute substantially to recovery of the
purine pool in the absence of supplementation with exogenous
purines.
An important role for maintaining cellular purine nucleotide
levels and promoting recovery of the pool after ischemia is also
suggested by the results of studies with enzyme inhibitors.
Cellular nucleotide levels at the end of ischemia, recovery of
ATP during the first two hours of reperfusion, and renal
functional parameters at 24 hours were all improved during
ischemia in vivo by inhibiting adenosine deaminase with 2'-
deoxycoformicin [74] or inhibiting 5'-nucleotidase with AMPCP
[84].
In contrast to the beneficial effects of manipulation of purine
metabolism in vivo, isolated rabbit proximal tubules were not
protected against oxygen deprivation injury when 250 tM ATP
concentrations were added to the medium, even though recov-
ery of cell ATP was improved with reoxygenation [831. How-
ever, multiple ATP additions during anoxia totaling 1 m, as
well as similar additions of ADP, AMP, adenosine, and inosine
were protective [79]. This level of added purines is in excess of
the concentrations (100 to 250 tM) which were required to
augment cell ATP of oxygenated tubules [71, 83], and probably
exceeds the concentrations of purines delivered to the kidney
after systemic infusion in vivo or maintained in the tissue after
manipulation of degradation in vivo, so the mechanism for
protection may have been different.
A major difference between the isolated tubule models and
ischemic acute renal failure in vivo is that virtually all injury in
the isolated tubules is evident during the defined period of
oxygen deprivation, while ischemic acute renal failure in vivo
includes injury which evolves during reperfusion when injured
but still viable cells in areas which are not fully reperfused could
be affected to a greater degree by provision of nucleotide
precursors. Furthermore, exogenous purines, via cell surface
receptors, can have vascular and direct tubular effects in
addition to alteration of cellular purine metabolism which could
modify the response to injury. Adenosine is involved in the
regulation of tubuloglomerular feedback and renal perfusion
[109] and has been shown to reduce transport-related injury in
the thick ascending limb [1101. Receptors for both adenosine
and ATP linked to phospholipase C and adenylate cyclase are
present in a variety of cell types including tubule cells, and may
influence a number of cell processes [ill—i 13]. Both adenosine
and ATP, via independent mechanisms, can modulate leuko-
cyte function [114—116]. Better maintenance of cellular nucleo-
tides during ischemia and recovery of ATP during reperfusion,
as observed in vivo with purine infusion [92, 85] or systemic
administration of agents altering purine metabolism [74, 84],
could also be secondary to generalized preservation of tubule
cell integrity related to primary effects on hemodynamics or cell
energy consumption by the test agents.
Acidosis
Tissue ischemia in the kidney, like that in other organs, is
characterized by decreases of pH secondary to release of H
during ATP hydrolysis [118] and accumulation of CO2. Al-
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though severe reductions of pH can potentially damage cells
[40, 119] and such damaging effects have been proposed for the
kidney [120, 121], substantial evidence indicates that decreases
of pH in the range seen during ischemia in vivo can also
enhance resistance to the damaging effects of oxygen depriva-
tion and some toxins. Initial reports of this effect described
better preservation of cell K1 in hypoxic renal slices at reduced
pH [122] as well as protective effects against anoxic injury to
myocardial tissue [123], Ehrlich ascites tumor cells [124] and
isolated hepatocytes [125]. More recent work detailing behavior
of a number of injury-related metabolic parameters in freshly
isolated hepatocytes [126] and renal proximal tubules [21, 127]
clearly showed the critical pH to be 6.9 to 7.0. In isolated
proximal tubules studied in suspension, susceptibility to hy-
poxic injury increased linearly as the pH was dropped from 7.5
to 7.0 by titrating the Krebs-Ringers bicarbonate-buffered me-
dium with HC1. Between pH 6.4 and 7.0, the cells were highly
resistant to injury [21].
The protective effects of reduced pH were not limited to
conditions where metabolic acidosis was induced by addition of
HC1 to tubule suspensions. When tubules were incubated at
high density as pellets during oxygen deprivation, they sponta-
neously lowered the surrounding pH to about 7.0, and showed
the same increased resistance to oxygen deprivation-induced
injury as seen in the suspended tubules kept at pH 7.0 or less
[21].
Protective effects of reduced pH have subsequently been
reported for suspensions of rat proximal tubules [127] and in the
isolated perfused rat kidney [128], where reduced pH also
decreased sensitivity to damage produced by elevated levels of
perfusate calcium [129]. Kidneys flushed with simple phosphate
buffered saline + sucrose solutions at pH 7.0 prior to warm
ischemia had better recovery of function than those flushed
with pH 7.4 solution [130]. Isolated rabbit tubules are also
protected by reduced pH against damage from ATP-depleting
metabolic inhibitors [131, 132] and ouabain [131], but not from
damage produced by tert-butyl hydroperoxide or ochratoxin A
[132]. Available studies do not suggest that reduced pH is
protective during cold preservation of kidneys [121, 133], but
this has not received extensive study.
Although direct measurements of intracellular pH during
kidney tubule injury models have not been reported, recent
studies with primary cultures of isolated hepatocytes, where
similar protective effects occur, are probably relevant. In
hepatocytes metabolically inhibited by a combination of cya-
nide and iodoacetate in pH 7.4 medium, intracellular pH
dropped to approximately 6.5 and remained there until imme-
diately prior to the apparent time of cell death when it rose
moderately just before abrupt leakage of bis-carboxyethylfluo-
rescein, the fluorescent pH probe. Cells incubated in low pH
medium showed the same sequence of changes, except the
period of intracellular acidosis and the time to cell death were
prolonged. A similar prolongation of the period of intracellular
acidosis and protection was produced by treatment with amil-
oride in pH 7.4 medium, while replacement of medium chloride
with gluconate or treatment with a disulfonic stjlbene or mon-
ensin to ameliorate the metabolic inhibitor-induced intracellular
acidosjs accelerated injury [134, 135].
The mechanism for protection by reduced pH is unknown.
Reduced pH can inhibit H-ATPases [136] and could affect
Na/H exchange, a process which can consume a substantial
amount of ATP in the proximal tubule [137]. ATP levels during
hypoxia were slightly preserved in the isolated rabbit proximal
tubules protected by reduced pH [21]; however, observations
that low pH did not markedly reduce respiration by oxygenated
tubules [21], that intracellular acidosis with normal medium pH
protected hepatocytes [135, 136], and that ATP levels were not
preserved during protection of isolated hepatocytes [126, 134]
or in the isolated perfused kidney [139] argue against a neces-
sary role for ATP preservation in protection. Maintenance of
ATP in some systems could simply reflect better general levels
of cellular integrity, as detailed elsewhere in this review to
explain improved ATP levels at the end of hypoxia in glycine-
protected tubules [140]. Better cellular integrity may also ac-
count for the improved preservation of AMP in tubules pro-
tected by low pH [21], although this could alternatively be
explained by inhibition of 5'-nucleotidase by reduced pH [721.
Reduced pH can decrease transmembrane Ca2 fluxes [141,
1421 and the affinity of calmodulin for Ca2 drops sharply as pH
is decreased from 7.5 to 6.5 [143, 144]. Thus, multiple Ca2-
calmodulin-regulated processes could be inhibited as pH de-
creases. Studies of plasma membrane phospholipases A2 and C
and mitochondrial phospholipase A2 have indicated pH optima
at greater than 7.0 with sharp decreases of activity below pH 7.0
[145—148]. Inhibition of phospholipase activity by reduced pH
via direct effects as well as via reductions of Ca2 availability
and Ca2-calmodulin binding could, therefore, contribute to
protection. However, the roles of all these events in oxygen
deprivation injury remain to be more completely defined, and
numerous other mechanisms for protection are possible includ-
ing effects on membrane recycling [149], the cytoskeleton [150],
cell-cell junctional permeability [1511, and the generation [1521
and metabolism [153] of reactive oxygen metabolites.
The protective effects of reduced pH are probably fully
expressed during ischemia in vivo and, therefore, do not
provide opportunities for further manipulations at that stage of
injury, but they must be carefully considered in the design of
experimental models for study in vitro. Additionally, as detailed
below, they provide a mechanism which may importantly
contribute to the expression of injury after reflow, since cor-
rection of pH at that time could exacerbate injury.
Cell volume alterations
Cellular volume regulation depends on active Na extrusion
and maintenance of a negative intracellular potential to exclude
C1 [154]. Both processes require Na,K-ATPase activity which
is limited by decreased ATP during ischemia so that uptake of
these extracellular solutes and osmotic swelling result [154].
Cell swelling is evident morphologically during renal ischemia
in vivo [24, 25, 155]. Both the swelling [24, 25, 155] and the
associated alterations of monovalent cation distribution [2] can
rapidly reverse during reperfusion. Similar rapid and complete
recovery of monovalent cation homeostasis is seen in surviving
cells after reoxygenation of isolated tubules [9, 211.
It is well established that mannitol is effective in alleviating
ischemic acute renal failure in vivo [156—159]. Addition of
impermeant solutes, sucrose or mannitol, to simple phosphate-
buffered saline flush solutions also improved structural and
functional preservation of kidneys subjected to warm and cold
ischemia [130, 160, 161]. This effect did not require hypertonic
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conditions, since it was fully expressed when electrolytes were
isosmotically replaced with the sugars [1611. Substitution of the
less permeant sugars, sucrose and mannitol, for dextrose in
solutions such as Collins and Euro-Collins used to preserve
kidneys in the cold for transplantation is beneficial [1601. Most
recently, a preservation solution in which chloride is replaced
by the less permeant anion, lactobionate, has shown great
promise for extending usable periods of cold storage for several
tissues, including the kidney [162]. This solution also contains
raffinose as an impermeant sugar, hydroxyethyl starch, adeno-
sine, glutathione and allopurinol. However, one report has
indicated that most of its beneficial effects were still present
when the starch, adenosine, glutathione, and allopurinol were
omitted 11631, suggesting that the impermeant solutes are most
responsible for the improved results.
In models of ischemic injury where erythrocytes are present,
fluid uptake from the vascular space by swelling endothelial and
tubule cells appears to lead to erythrocyte clumping and vas-
cular obstruction that contributes to further ischemic damage
during reflow [164, 165]. Thus, protection by impermeant
solutes in this setting may not be on subcellular processes
evoked by oxygen deprivation, but rather on vascular-neph-
ronal interactions which contribute to efficacy of reoxygen-
ation. Effects of impermeant solutes to relieve intratubular
obstruction by promoting a diuresis and, as a result, decreasing
high intratubular pressures that would further contribute to
peritubular vascular obstruction may also be involved in this
mechanism [1661. Actions of some irnpermeant solutes to
directly 'stabilize' membranes [28, 1671 or to alter effects of
toxic intermediates such as reactive oxygen species [1681 have
been suggested to contribute to protection.
Protection by polyethylene glycol of primary cultures of
tubule cells injured by anoxia has been described [1691, but the
effect was subsequently not considered to be due to actions on
volume mechanisms [28]. Mannitol had little effect on hypoxic
or metabolic inhibitor-induced injury to isolated tubule suspen-
sions [13t], although, used in the same fashion, it reduced
swelling and protected against injury due to ouabain or expo-
sure to a high K concentration medium [170]. The absence of
greater protection in isolated tubule hypoxia models favors
vascular and nephronal processes as the main targets for
protection, in vivo.
The high-K medium isolated tubule studies [1701 are of
interest with regard to mechanisms for protection by tissue
preservation solutions, since these solutions contain similarly
high K levels. Excellent preservation of cell ATP was seen in
high K medium even though respiration was inhibited and
massive swelling took place. Only a modest degree of lethal cell
injury as quantified by lactate dehydrogenase (LDH) release
occurred and this injury was completely prevented by mannitol,
which ameliorated but did not totally eliminate the swelling.
These data suggest synergistic effects of maintaining cellular
ATP and volume in the protective actions of high potassium-
content preservation solutions containing impermeant solutes
[170].
Calcium
Disturbances of cellular calcium metabolism have received
much attention in studies of the pathophysiology of cell injury
in general [33, 17 1—175] and in the tubulointerstitial response to
ischemia [32, 61, 176]. Work with many cell types has shown
that cytosolic free calcium is normally kept at about 100 flM,
1/10,000th of the extracellular level, exchangeable intramito-
chondrial Ca2 is extremely low, a hormone sensitive pool
sufficient to raise cytosolic free calcium to above 1 M is
present in microsomes, and additional Ca2 is bound to cellular
macromolecules [124, 177, 178]. The endoplasmic reticulum
Ca-ATPase and plasma membrane Ca-ATPase and Na7Ca2
exchange regulate free cytosolic Ca2 at physiologic resting
levels [124, 177]. Mitochondrial uptake and retention of Ca2
becomes substantial only when cytosolic levels exceed 400 to
500 flM [179], as could be the case during injury.
Calcium overload is characteristic of tissues with lethally
injured cells because loss of the plasma membrane barrier to
calcium allows unrestricted uptake by mitochondria. Even
damaged mitochondria can sustain high intramitochondrial
Ca2 levels [176, 180, 181]. This has been shown for both toxic
and ischemic injury to the kidney, where mitochondria exhibit
the morphologic features of Ca2 overload [26, 60], and very
high Ca2 levels are measured in isolated mitochondria [59, 61,
176, 1821 and using electron probe microanalysis [26]. Even
when it occurs after lethal cell injury, mitochondrial Ca2
uptake is an active process utilizing any available ATP as well
as electron transport. This is illustrated by the behavior of
isolated proximal tubules in suspension. During hypoxic injury,
the cells gain substantial amounts of calcium which is predom-
inantly localized in mitochondria [9, 21, 183]. During complete
anoxia, which produces an apparently similar amount of injury,
no such Ca2 uptake is observed [9, 184], presumably because
mitochondrial electron transport is not available to drive it.
More relevant to the question of a pathophysiologic role for
Ca2 is whether either cytosolic free calcium or mitochondrial
calcium increase prior to lethal cell injury as a result of
enhanced membrane permeability, reversal of the normal out-
ward direction of Ca2 movement by Na/Ca24 exchange
[185], diminished ATP to drive active Ca2 extrusion and
non-mitochondrial sequestration, or damage to extrusion and
sequestration enzymes [186]. Recent studies with cultured
myocytes have clearly demonstrated such prelethal distur-
bances of cellular Ca2 homeostasis [187, 188]. In studies of
toxic injury to the kidney in vivo where mitochondrial function,
calcium content, renal function, and histopathology were as-
sessed during both prelethal and lethal stages of injury, no
evidence of mitochondrial Ca2 overload was found for long
periods during the prelethal stages of injury [182]. A similar
relationship between the appearance of necrotic cells and tissue
calcium overload was found when mitochondria were isolated
from ischemic kidney [59] under conditions which had been
shown to minimize artifactual uptake of Ca2 and mitochon-
drial damage during isolation [180], in that little or no increase
of mitochondrial calcium had occurred at the end of 50 minutes
of ischemia or during the first three hours of reflow. The major
change in mitochondrial Ca2 was between 3 and 18 hours of
reflow [59], the time when substantial numbers of necrotic cells
begin to appear in this model [25, 50, 52]. In oxygen deprived,
isolated proximal tubule preparations, increases of total cell
Ca2 were only measured at times when lethal cell injury had
occurred by other criteria [211, and both electron probe studies
[189] and studies of intracellular Ca2 compartmentation using
digitonin-permeabilized cells [183] indicated that Ca2 overload
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was predominantly in mitochondria from cells that were already
lethally injured. These observations argue against an early or
prolonged phase of elevated cytosolic Ca2 during ischemic
proximal tubule cell injury, and dictate caution in the interpre-
tation of total cell calcium measurements which can reflect the
contribution of post-lethal mitochondrial uptake.
The role of Ca2 as a toxic factor during ischemic injury is
supported by the results of studies where extracellular Ca +
levels were varied. Increasing perfusate Ca2 aggravated hy-
poxic injury in the isolated perfused kidney [1901. Rats with
hypercalcemia secondary to vitamin D treatment were more
susceptible to ischemic acute renal failure [191]. Removing
medium Ca2 ameliorated anoxic injury to cultured tubule cells
[192], hypoxic injury to the medullary thick ascending limb of
the isolated perfused kidney [193], and anoxic injury to freshly
isolated proximal tubules [91. Interpretation of studies using low
Ca2 conditions, however, can be complicated by primary
deleterious effects resulting from Ca2 removal [9, 175, 194—
1981. It is of interest in this regard that studies of varying Ca2
levels in kidney preservation solutions indicated optimal results
when a moderate concentration of Ca2, 0.5 m, was present.
Higher and lower levels of Ca2 promoted damage [1621.
Calcium channel blockers have been reported to ameliorate
oxygen deprivation-induced injury both in vivo and in vitro
[199—204]. It remains somewhat controversial whether these
effects are primarily on vascular or tubular cells [61, 205, 206].
Protective effects thus far reported in freshly isolated tubule
preparations have been relatively modest [204, 207]. That Ca2
channel blockers would be, at most, partially effective is not
surprising given the likelihood that a variety of permeability
pathways in addition to dihydropyridine-sensitive ones would
be involved in changes of plasma membrane Ca2 movements
during injury. Additionally, attribution of the effects of Ca-
channel blockers solely to alterations of Ca2 fluxes is compli-
cated by actions of some of the agents as calmodulin inhibitors
[208].
In studies which have directly assessed cytosolic free Ca2,
cultured tubule cells exposed to anoxia [185], metabolic inhib-
itors [209, 210] or mercuric chloride [210], all showed increases
of cytosolic free Ca2. In the mercuric chloride-treated cells,
the changes were particularly prominent in blebs. However, the
increase of Ca2 produced by anoxia were modest in degree
[1851, and a preliminary report has suggested that freshly
isolated proximal tubules do not have substantial increases of
cytosolic free calcium when made anoxic [211].
Recent measurements of cytosolic free Ca2 in metabolic
inhibitor-treated primary hepatocyte cultures may be relevant
to the findings with the fresh tubules in that the hepatocytes also
showed either no early increases or relatively modest increases
of free Ca2 in either the cytosol as a whole or in blebs whose
rupture apparently accounted for the transition to lethal cell
injury [212, 2131. The immediate prelethal period was charac-
terized by a period of instability in which cells did show more
substantial increases of cytosolic calcium, but these increases
were prevented by use of low Ca2 (600 to 800 LM) medium
without altering the susceptibility of the cells to injury [213].
The failure of cytosolic Ca2 to increase early and more
consistently during ATP depletion raises the possibility that the
ATP-depleted state decreases membrane Ca2 permeability.
There are precedents for this. It has been suggested that anoxia
produces a generalized decrease of membrane cation perme-
ability as an adaptive, auto-protective mechanism [15, 16]. A
dramatic decrease in 45Ca2 uptake by Nat-loaded isolated
myocytes was seen after reduction of ATP levels by metabolic
inhibitors [214]. The mechanism for this and its general appli-
cability remains to be established. An interesting possibility is
that intracellular acidosis contributes to this phenomenon by
decreasing transmembrane Ca2 fluxes [141, 142, 215].
These findings in renal and non-renal tissues indicate that the
changes of cellular Ca2 handling involved in promoting acute
cell injury are complex. Substantial increases of cytosolic free
Ca2 overload may not be uniformly early mediators of cell
injury during ischemia, but probably can contribute to the
transition to lethal cell injury. As yet there is little information
on the behavior of cytosolic free Ca2 during conditions anal-
ogous to reperfusion.
Disturbances of cell Ca2 metabolism may also contribute to
the response to ischemic renal injury beyond the acute phase,
because Ca2 accumulation by lethally injured cells can pro-
duce locally high Ca2 concentrations that would promote
damage to neighboring cells, serve as foci for the development
of nephrocalcinosis, and alter responses to physiological regu-
lators of cytosolic free calcium in neighboring cells. This area of
study remains largely unexplored; however, the potential for
experimentally manipulating the degree of pathological calcifi-
cation is suggested by recent work showing that saline loading
animals prior to induction of mercuric chloride nephrotoxicity
dramatically lowers tissue Ca2 deposition without necessarily
reducing the extent of lethal tubule cell injury [214].
Phospholipids
Alterations of phospholipid metabolism during ischemia are
well documented [217—2201 and potentially involve multiple
processes. Phospholipid degradation can be promoted by in-
creases of Ca2 [217, 221—223], peroxidation of phospholipid
polyunsaturated fatty acids [224—2261, and, possibly, activation
of endogenous phospholipases [227] resulting from proteolysis
or other ischemia-induced degradative processes. At the same
time, ischemia-induced lack of ATP may inhibit reacylation of
lysophospholipids [228, 229], de novo phospholipid synthesis
[230], esterification of free fatty acids to glycerol to form
triacylglycerol [44], and esterification of free fatty acids to
coenzyme A required for mitochondrial oxidative metabolism
[231]. Further metabolism of any acyl CoA and acylcarnitine
esters already present will be prevented by suppression of
mitochondrial electron transport [231]. The net result of all
these factors will be loss of phospholipid mass and accumula-
tion of breakdown products potentially including free fatty
acids, lysophospholipids, diacylglycerol, acyl-CoA and acylcar-
nitine esters, and inositol phosphates. Loss of phospholipid
mass [217] and membrane disrupting effects of the degradation
products [219, 233—235] could contribute to the development of
injury by interfering with the structural support and permeabil-
ity barrier properties of both the plasma membrane and of
subcellular organelle membranes.
Isolated mitochondria provide an excellent illustration of a
number of these effects. Ca2 uptake in the presence of
phosphate induces functional deterioration due to both specific
and generalized increases of inner membrane permeability [180,
236, 237] which are accompanied by release of free fatty acids
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in a pattern consistent with activation of phospholipase A2
[236—238]. Functional deterioration can be blocked by phospho-
lipase inhibitors [62, 180, 236, 237, 239] or trapping of fatty
acids with albumin [180]. Furthermore, the process is stimu-
lated by the presence of reactive oxygen metabolites [62, 240].
Demonstrating these process during injury to intact cells has
been more difficult. While there is little doubt that phospholipid
degradation with formation of free fatty acids and lysophospho-
lipids occurs in tissues with ischemic cell damage, the issue is
complicated by the continuation of these processes after lethal
injury occurs when they are no longer pathogenetically impor-
tant. Thus, measurements on tissues or cell preparations which
already contain lethally injured cells do not establish that the
observed changes are pathogenetically important.
After 15 minutes of ischemia in vivo induced by clamping the
renal artery, a time when tubule cell disruption and lethal cell
injury are not yet present, there were two- to sixfold increases
of both saturated and unsaturated free fatty acids and as well as
a significant increase of lysophosphatidylcholine [2191. De-
creases of phospholipid mass were not resolved at that time
point, but the increases of free fatty acids could not be
explained by loss of triglycerides. Further increases of free fatty
acids accompanied by decreases of phospholipid mass (phos-
phatidyicholine, phosphatidylinositol) were found at 60 min-
utes, although interpretation of these changes is complicated by
the presence of cell necrosis at that time [219].
Cultured tubule epithelial cells of the LLC-PK1 line required
a combination of glucose deprivation and mitochondrial elec-
tron transport inhibition with antimycin to maximally lower
ATP levels and induce lethal cell injury, which occurred after
several hours [44]. This allowed definition of a relatively early,
large increase of both saturated and unsaturated free fatty acids
which accompanied the initial rapid drop of ATP levels during
the first hour of exposure to antimycin + zero glucose, well
before lethal cell injury. Free fatty acid accumulation continued
during five hours of incubation at the end of which time most
cells were dead. At five hours there were significant decreases
of phospholipid content (predominantly of phosphatidylcho-
line). However, cells exposed for five hours to antimycin plus a
low concentration of glucose (0.55 mM) showed similar de-
creases of phospholipid content, yet did not develop lethal cell
injury. The latter group also did not show any increases of free
fatty acids. These data implicate prelethal accumulation of fatty
acids as a pathogenetic event in this system and suggest that
loss of phospholipid mass is less important than fatty acid
accumulation [44].
Work with freshly isolated tubule preparations has thus far
been more equivocal. Studies using both labeled arachidonate
[2411 as well as colorimetric and gas chromatographic assays of
free fatty acid levels [242] have shown increased release of free
fatty acids by hypoxic rabbit tubules, but only at hypoxia
durations greater than 15 minutes when lethally injured tubules
are already present. Consistent changes of phospholipid levels
were not found [242]. Like energy-depleted erythrocytes [243],
hypoxic proximal tubules were more sensitive to the membrane
damaging effects of exogenous phospholipases than oxygenated
tubules [244].
Phospholipase inhibitors such as those effective in protecting
isolated mitochondria from phospholipase A2-induced damage
have given equivocal results with isolated tubule preparations.
Mepacrine provided modest, transient protection to isolated rat
tubules, but bromphenacyl bromide was not effective in the
same preparation [245]. Neither mepacrine nor dibucaine
([2271, Weinberg, unpublished data) altered oxygen depriva-
tion-induced injury to isolated rabbit tubules. Fatty acid free
albumin, which is very effective against injury to isolated
mitochondria [180] and which prevented injury due to exoge-
nous phospholipases [244], did not ameliorate hypoxic injury
[241, 242]. Chlorpromazine has been reported to ameliorate
ischemic renal injury in vivo [2461 as it does hepatic ischemia
[217], however, altered thermoregulation and the potential for
other systemic effects complicates these data. Since phospho-
lipase inhibitors do not uniformly affect all phospholipases and
albumin added to the medium will not necessarily have access
to important intracellular sites of injury, all these observations
must be considered with caution at present.
Phospholipases in addition to phospholipase A2 as well as
lipases are likely to be involved in ischemia-induced lipid
breakdown and elevations of free fatty acids. Increases of
diacylglycerol and phosphatidic acid in ischemic kidney tissue
[219] are compatible with activation of phospholipase C and D,
respectively, although other mechanisms are possible. The
increases of all classes of free fatty acids, saturated, monoun-
saturated and polyunsaturated, which have been found [219] are
also consistent with a generalized disruption of lipid metabo-
lism.
Free fatty acids are not truly free' in the cell. They are
generally associated with other macromolecules, which ac-
counts for their detergent properties and toxicity. However,
binding sites may also serve as buffers to alleviate toxicity.
Fatty acid-binding proteins are present at high concentrations in
many cell types [247] and are found in the kidney [248]. Their
significance during ischemic injury is unknown. Esterification
to triglycerides may represent another adaptive response to
energy-deprived conditions which can continue at relatively
low levels of ATP. Increases of triglycerides were found during
the LLC-PK1 cell studies detailed above [44] in cells treated
with antimycin and low concentrations of glucose. These cells
had severe but submaximal decreases of ATP and did not
develop lethal cell injury or accumulation of free fatty acids.
Triglycerides decreased during renal ischemia in vivo, but the
decline was late (60 mm), was relatively modest in magnitude,
and was limited to palmitic and stearic acid-containing species
[219].
Amino acids and glutathione
Recent studies of oxygen deprivation-induced injury to iso-
lated proximal tubule preparations have revealed an important
role for the small amino acids, glycine and alanine, in maintain-
ing cell viability [22, 23, 142, 261]. Supplementation of the
tubule incubation medium with glycine at concentrations rang-
ing from 0.25 to 2 m provided major protection against
hypoxic injury. Glycine had to be present during the period of
hypoxia. Preincubation was not required and was not sufficient
for protection if preincubated tubules were resuspended in
glycine-free medium at the start of hypoxia [22]. Protection was
manifested by continued exclusion of vital dyes, absence of
release of intracellular enzymes, and recovery of normal cell
respiration, ATP levels, and K transport with reoxygenation.
Similar protection by glycine was seen when tubules were
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injured by chemical inhibitors of mitochondrial ATP production
[2491. Although protected preparations had slightly higher ATP
levels in several of the hypoxia studies [22, 23], this was not
found in other hypoxia studies [140] or in the experiments with
metabolic inhibitors [2491, indicating that preservation of cell
ATP is not the mechanism for protection.
Cellular glutathione fell during hypoxia, addition of glutathi-
one had protective effects similar to those of glycine, and both
agents maintained higher tubule cell glutathione levels during
hypoxia and metabolic inhibition [140, 249, 261]. However,
glutathione was rapidly broken down to its three amino acid
components, cysteine, glutamate and glycine, during incuba-
tion. Of these amino acids, only glycine was protective [22]. In
the presence of the y-glutamyl cysteine synthetase inhibitor,
buthionine sulfoximine, or the glutathione reductase inhibitor,
bis-chloroethylnitrosourea, increments of cell glutathione in
protected tubules were eliminated, but protection was main-
tained [140, 249, 261]. Furthermore, depletion of cellular gluta-
thione in the absence of glycine by these agents did not appear
to substantially exacerbate injury [140, 249]. Roles for glutathi-
one as an intracellular antioxidant and participant in other
detoxification reactions in the kidney and other tissues are well
documented [250—259], and it is a widely held view that a
critical, minimal level of cellular glutathione is necessary for
prevention of oxidant injury to cellular lipids and proteins [173,
252, 260]. Nonetheless, glutathione seems to have little role in
proximal tubule lesions mediated by ATP depletion other than
as a source of glycine [22, 140, 249, 261].
Glycine's protective actions are probably not limited to the
proximal tubule, since they appear to account for the well
documented beneficial effects of amino acid mixtures on the
spontaneous hypoxic injury which occurs in medullary thick
ascending limbs of isolated rat kidneys perfused with simple salt
solutions [262, 263]. Alanine and glycine may also be important
for preventing early functional deterioration of proximal tubule
function in the isolated perfused kidney [2641. High concentra-
tions (—5 mM) of alanine have frequently been included in
solutions used for microperfusion studies [265—267]. It is pos-
sible that the structurally protective effects of alanine contrib-
ute to the improvements of function produced by alanine in that
setting.
The actions of glycine are not limited to injury induced by
hypoxia or metabolic inhibition. Glycine protected against
lethal cell injury to tubule suspensions produced by ouabain
without altering ouabain's primary inhibitory effects on Na-K-
ATPase or the resulting changes of cellular monovalent cation
content and volume. This protection was accompanied by
substantial amelioration of an accelerated phase of ATP deple-
tion which appeared to closely precede the lethal event [170].
Glycine also protected against damage produced by incubation
of tubules in Ca-free media [1961 and damage induced by
incubation in medium with abnormally high or low levels of
phosphate [268]. Glycine did not apparently protect against
damage produced by tert-butylhydroperoxide [254] or against
damage produced by mercuric chloride [196].
The effects of alanine, to the extent that they have been
studied, appear to be similar to those of glycine [23, 2611.
Among other structurally related compounds, /3-alanine, and
l-aminocyclopropane-l-carboxylic acid also provide substantial
protection and D-alanine is effective, but is significantly less
active than the other compounds. Bulkier amino acids, includ-
ing serine, a major metabolite and potential source of glycine in
the kidney, are not effective. Substitutions on glycine's car-
boxyl and amino groups or their removal results in loss of
potency [269]. These protective amino acids are also active at
neuronal glycine receptors, however, the activity profile does
not coincide with that for either of the two receptor types [269].
Although there are many potential metabolic pathways for
glycine, most of these are unlikely to be contributing to protec-
tion because they require ATP and/or synthetic processes,
while glycine's protective actions occur during profound ATP
depletion without preincubation [22, 140]. Consistent with this,
little glycine metabolism was detected during protection [22].
Conjugation of glycine by glycine-N-acyltransferase with acyl-
coenzyme A compounds to form acylglycines [270—272] is
reaction of glycine which could occur during states of ATP
depletion and which involves potential mediators of injury.
Glycine-N-acyltransferase has been found in both kidney and
liver [272]. However, substantial acylglycine production by
glycine-protected tubules has not been found [273].
Na-dependent apical glycine uptake with intracellular gly-
cine concentration has been well characterized in the proximal
tubule [274]. Active Nat-dependent basolateral transport also
occurs [274]. In suspension, under the conditions which have
been most extensively used thus far to study glycine's protec-
live effects, oxygenated tubules maintain intracellular glycine
concentrations three to four times greater than medium levels.
With deenergization or inhibition of Na-K-ATPase by ouabain,
cellular levels rapidly equilibrate with those of the medium. The
same equilibrium is seen when glycine is added after deenergi-
zation or ouabain treatment [275]. This indicates that glycine
added to the medium becomes readily available within cells and
also explains the failure of preincubation with glycine to protect
cells in suspension, since cellular glycine equilibrates with a
very large glycine-free extracellular space once cells are deen-
ergized. It also suggests that deenergization and inhibition of
Na transport occurring during preparation of tubules may
substantially deplete endogenous glycine, setting the stage for
maximal protective effects of supplemental amino acids. Al-
though not yet reported in detail, it is likely that the same
considerations apply to alanine, except they are further com-
plicated by the utilization of alanine for transamination and
oxidative metabolism.
Various studies have suggested that amino acids modify the
response to ischemic acute renal failure in vivo, however, most
used mixtures of multiple amino acids and both beneficial and
deleterious effects have been reported [276, 277], reflecting the
heterogenous properties of different amino acids including the
potential for direct tubule cell toxicity [278, 279]. Whether
glycine supplementation in vivo will be protective remains to be
determined. Preliminary reports have suggested beneficial ef-
fects in both uranyl- [2801 and in cis-platinum-induced nephro-
toxicity [281], but the mechanisms of protection in these
systems have not yet been fully described. The available data
on glycine levels required for protection and on glycine fluxes
during injury in vitro [275] suggest the glycine (and alanine) will
likely be present at protective concentrations during many
forms of injury in vivo. During ischemia, for example, glycine
leaving tubule cells as a result of deenergization would be
diffusing into an extracellular space much smaller than that
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present in suspensions of tubules, maintaining protective levels.
However, susceptibility of tubule cells to alterations of glycine
concentration in the physiological range and the variability of
circulating level between species and as a function of the
dietary state [282—2841 provide conditions which could allow
expression of protective effects. This will require further study.
The data on effects of manipulating glutathione in vivo are
conflicting. Increasing renal glutathione levels by infusion of
GSH or several other maneuvers protected against ischemic
injury in a clamp ischemia model [2851. However, doubling of
tissue glutathione prior to ischemia by GSH infusion was not
protective against injury in a hypoperfusion model [2861. In
another study of renal ischemia, decreasing tissue glutathione
levels by treatment with buthionine sulfoximine was not dele-
terious, while large increases of tissue glutathione produced by
infusions of glutathione-monoethylester promoted injury [2871.
More information about the metabolism of glutathione and its
components after systemic infusion is needed to reconcile these
observations.
Oxidant injury during renal ischemia
Reactive oxygen metabolites (ROM) are now recognized to
be ubiquitous mediators of cell damage [2881. Importantly, this
has been shown for a number of tissues to include ischemia-
reperfusion injury where sources of ROM include metabolism
by xanthine oxidase of hypoxanthine and xanthine to uric acid
with production of superoxide [289, 290], autoxidation of ubi-
quinone and NADH dehydrogenase during electron transport
by damaged mitochondria [12, 14, 2911, and infiltrating inflam-
matory cells [290, 292]. Catecholamine metabolism [293], ara-
chidonic acid metabolism by prostaglandin endoperoxide syn-
thetase [294, 295], and cytochrome P450-mediated processes
[2961 can also contribute. Iron plays an important role in many
systems by catalyzing the production of highly damaging hy-
droxyl radical from H202 [297, 298].
Interactions of ROM with many other pathophysiologic ele-
ments of ischemic damage have been identified. Purine nude-
otide degradation provides the substrate for xanthine oxidase
[2901. Elevated free calcium levels have been proposed to
activate calmodulin-regulated proteases converting the NADH-
dependent xanthine dehydrogenase, which does not generate
ROM, to xanthine oxidase [290, 299]. Amphiphilic lipid metab-
olites such as CoA and carnitine esters and lysophospholipids
which can accumulate during ischemia promote peroxidative
membrane injury [3001. Phospholipids rich in polyunsaturated
fatty acids are preferential targets for peroxidative damage and,
once peroxidation has occurred, are preferentially degraded by
phospholipase A2 [224—2261. Even minimal oxidant damage can
denature proteins resulting in loss of function or increased
susceptibility to proteolysis [301, 302]. Oxidants can also inap-
propriately activate proteins with damaging effects as shown for
neutrophil collagenase [303]. Oxidant damage to nucleic acids
limits cell repair and proliferation [304, 3051.
There are several lines of evidence supporting a role for ROM
in ischemic tubulointerstitial injury. Two markers of lipid
peroxidation, malondialdehyde [306, 307] and ethane [308],
have been detected during models of renal ischemia, The ratio
of GSSG/GSH, a parameter which can reflect oxidant stress in
cells, was elevated during renal ischemia [3091. Consumption of
dimethylthiourea, another index of 'oxidative stress', was in-
creased in isolated perfused kidneys that had been previously
ischemic in vivo [310].
Multiple types of oxidant scavengers or reagents modifying
ROM generation ameliorated ischemic renal injury in vivo.
These include: superoxide dismutase but not catalase [307],
allopurinol which can reduce ROM generation by inhibiting
xanthine oxidase and can act directly as a hydroxyl radical
scavenger [307, 311—313], inhibition of xanthine oxidase by
tungsten feeding [314] and the radical scavengers, DMSO [315]
and dimethylthiourea [307, 310]. Mannitol is known to have
scavenging properties [168]. Deferoxamine provided protection
against glycerol- [316, 317] and hemoglobin-induced [316] acute
renal failure, consistent with a role for Fe-dependent hydroxyl
radical generation in injury. In ischemic acute renal failure,
inulin-linked but not dextran-linked deferoxamine was protec-
tive [318], suggesting protective effects occurred from the
tubule lumen rather than the vascular space and implying
tubules rather than vascular elements as the cells most affected.
Rapid conversion of xanthine dehydrogenase to xanthine oxi-
dase has been documented in isolated perfused kidneys per-
fused after ischemia in vivo [314]. Much slower conversion
occurred during ischemia [319]. Reperfusion of ischemic iso-
lated kidneys with neutrophils produced vascular and endothe-
hal cell damage and impaired function via ROM-mediated
mechanisms [320]. Neutrophil depletion ameliorated ischemic
acute renal failure [321, 322].
Thus, a variety of observations support a role for ROM in
ischernic-reperfusion injury to the kidney and implicate purine
degradation, Fe-mediated production of hydroxyl radical, and
infiltrating neutrophils as sources of the ROM. However, for
many of these observations there are also conflicting reports in
equally well validated experimental systems. Protective effects
of superoxide dismutase and allopurinol were not observed and
malondialdehyde generation was not found when tissue values
were corrected for interference from the hemoglobin of trapped
RBCs [3231. Probucol, an antilipemic agent with antioxidant
properties, provided transient protection immediately after
ischemia, but potentiated the tissue damage which evolved over
24 hours [326]. Oxypurinol, significantly inhibited degradation
of hypoxanthine and somewhat improved recovery of adenine
nucleotides but did not protect against histologic damage or
functional loss [82]. Increasing tissue hypoxanthine content did
not exacerbate injury [82]. Significant increases of neutrophils
were not found in reperfused kidneys [326] and interference
with neutrophil availability by anti-neutrophil serum [324, 325],
nitrogen mustard [326], or monoclonal antibodies against adhe-
sion receptors [325] did not alter the course of ischemic acute
renal failure. Furthermore, improvement of renal perfusion in
the first one to four hours immediately after ischemia by
infusion of atrial natriuretic peptide dramatically protected
against the subsequent appearance of lethal tubule cell injury
and the associated functional changes [327, 328], indicating that
the net effects of increased reoxygenation are favorable, not
deleterious. Also consistent with this are observations that
maneuvers introduced immediately after ischemia to reduce
vascular obstruction secondary to erythrocyte aggregation have
beneficial effects [164].
Remarkably little damage attributable to ROM is seen in
isolated proximal tubule models of hypoxic injury. Neither
rabbit kidney nor isolated rabbit tubules appreciably metabolize
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nucleosides beyond hypoxanthine [77, 79, 329] and neither
allopurinol nor increases of medium hypoxanthine levels mod-
ified the response of isolated tubules to injury [77, 96]. Further-
more, injury to isolated rabbit tubules occurs almost exclu-
sively during hypoxia. Unequivocal reoxygenation injury has
not been found [9, 21]. Rat tubules and kidney as a whole show
higher levels of xanthine oxidase activity than found in the
rabbit [80—82]. Isolated rat tubules also had an identifiable
component of reoxygenation injury, although it was less than
that which occurred during anoxia. However, allopurinol,
which inhibited xanthine oxidase in the preparation, had no
effect on either component of injury [81, 330].
Hypoxic injury to isolated rabbit tubules was not ameliorated
by a variety of oxidant-modifying agents at concentrations
known to be effective in those cells and in other cell types
against unequivocal oxidant insults [22]. Protective effects of
glutathione were the major exception to this pattern, however,
as detailed elsewhere in this chapter, these were found to be
entirely attributable to its component amino acid, glycine,
which has not been reported to have antioxidant properties [22,
140].
Although not extensively studied, intrinsic antioxidant de-
fense mechanisms of tubule cells may be very potent. Ten m
hydrogen peroxide, a highly toxic concentration for other cell
types [331, 332], did not substantially damage proximal tubules
in suspension unless glutathione was depleted or catalase was
inhibited [333]. The proximal tubule preparations studied to
date have been obtained mainly from cortex where Sl and S2
segments predominate. Whether unique metabolic characteris-
tics of S3 segments [32, 334] or medullary thick ascending limb
tubules will result in greater susceptibility to oxidant damage
that contributes to their behavior during or after ischemia
remains to be determined.
Recent data from studies of non-renal tissues also dictate
caution in the interpretatiOn of ROM effects during ischemic
acute renal failure. Several reports have indicated that conver-
sion of xanthine dehydrogenase to xanthine oxidase is a rela-
tively slow and late event [290, 319, 335, 3361. Furthermore,
there are major species differences in activity of xanthine
oxidase. It is virtually undetectable, for example, in human and
rabbit heart [337—3391. As detailed above, it has negligibly low
activity in rabbit proximal tubules and this is also the case for
whole rabbit kidney [77, 79, 329]. Human kidney also appears
to have relatively low xanthine oxidase activity [340]. Consis-
tent with this and similar to results from the studies with
isolated rabbit tubules, very little degradation beyond hypox-
anthine was seen in human kidneys stored in preservation
solutions containing high concentrations of adenosine [3401. An
unusually high susceptibility to oxidant damage of rat tissues as
compared to human tissues is also indicated by work showing a
30-fold greater rate of spontaneous auto-oxidation in homoge-
nates of rat kidney as compared to human kidney [341]. It is
also of note that the activities of non-mitochondrial oxidases
such as xanthine oxidase may be limited at physiological tissue
P°2 [67, 336]. This may be particularly relevant in view of the
relatively low p02 of normally perfused kidneys [6—8].
Endothelial cells have been suggested to be important sites of
xanthine oxidase and oxidant damage during ischemia-reperfu-
sion [339, 342, 343]. It is tempting to attribute a role to them in
promoting glomerular hemodynamic changes as well as in the
medullary congestion seen during ischemic acute renal failure
[1, 25, 27, 164, 344]. Alterations of the glomerular endothelium
have been described during ischemic acute renal failure, but
they are limited to mild swelling and decreases of the size of
fenestrae and tend to be transient [155, 345, 346]. Lethal
endothelial cell injury as found in the tissue culture models [339,
342, 3431 has not been reported. Recent work does, however,
support the notion that decreased endothelial cell production of
endothelium-derived relaxing factor is one factor which con-
tributes to the elevated renal vascular resistance [19] and
abnormal autoregulation [205, 345, 347, 348] seen after ischemic
acute renal failure. Smooth muscle damage likely also contrib-
utes [345].
Taking all of this information together, at present it is safest
to conclude that oxidant damage has a role in a number of forms
of renal ischemic-reperfusion injury, but it cannot be consid-
ered either the central process or even a necessary one to
account for the tubule cell damage which predominates early in
experimental models of ischemic acute renal failure. Further-
more, xanthine oxidase-mediated ROM production and injury
does not appear to be strongly expressed in some species,
including man, so data from rat models about this process must
be interpreted with particular caution.
Proteases
Proteases in lysosomes, the cytosol, and associated with the
cell membrane [349, 350] could contribute to tissue damage
during ischemia. Intracellular acidosis during ischemia would
favor expression of lysosomal protease activity because of the
acidic pH optima of those enzymes [351]. Although there is
little recent work, most data do not favor a prelethal pathoge-
netic role for lysosomal hydrolases during acute cell injury [32,
34, 352, 353].
Of greater interest is the potential for involvement of the
calcium-activated neutral cysteine protease [354, 355], calpain.
High and low affinity (relative to Ca2) forms of the enzyme as
well as an autocatalytic effect of Ca2* have been described
[354]. The enzyme is both cytosolic and membrane associated
[354, 356, 357] and activity may be regulated by membrane
phospholipids as well as by a specific inhibitor protein, calpista-
tin [354, 358]. Calpain has been implicated in the control of cell
membrane fusion, receptor expression, activation of kinases
including protein kinase C, cytoskeletal proteins and membrane
channels [354, 355, 359, 360]. Both forms of calpain and
calpistatin are found in kidney and have been reported to be
present in tubule cells [361—363]. Renal brush border mem-
branes are very rich in proteases such as meprin and endopep-
tidase 24.11 as well as expopeptidases [349]. Their regulation
and potential involvement during injury has not been studied.
ATP-dependent proteases and ubiquitin, which targets dam-
aged proteins, are widely distributed [349, 350]. As yet there is
little information about their role during acute cell injury in the
kidney or other tissues.
In a preliminary report [364], primary cultures of S3 proximal
tubule segments were protected against anoxic injury by L-3-
carboxy-trans-2 ,3 -epoxypropionyl-leucylamido-(4-guanidino)
butane (E64), a cysteine protease inhibitor active against cal-
pain [365]. Inhibitors of lysosomal proteolysis and other non-
lysosomal proteases were not effective [364. Freshly isolated
hepatocytes with elevated cytosolic calcium secondary to cys-
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tamine, exogenous ATP, or the divalent cation ionophore,
A23 187, had accelerated protcolysis associated with blebbing
and cell death [366, 3671. The proteolysis, blebbing, and cell
death were substantially ameliorated by antipain and leupeptin,
two cysteine-protease inhibitors active against calpain. Lyso-
motrophic reagents did not have the same protective effect,
suggesting that leupeptin and antipain were not acting via
effects on lysosomal proteases [366, 3671. In contrast, cultured
hepatocytes treated with the same agents did not exhibit injury
related to proteolysis [3681.
Cytoskeleton and cell polarity
There are multiple mechanisms by which ischemia-induced
reductions of cell ATP, elevation of cytosolic Ca2, phospho-
lipid degradation, and abnormal production of reactive oxygen
metabolites could alter cytoskeletal components and cytoskel-
etal-membrane interactions during ischemic cell injury.
1) ATP is required for both polymerization and depolymer-
ization of actin and tubulin [369—3711 as well as for actin-myosin
interactions [372]. GTP is required for polymerization of tubulin
[373].
2) Ca2 mediates the interactions of actin and myosin [374]
and regulates microtubule formation [375]. It also regulates the
effects of actin binding proteins. These include gelsolin and
profilin, which control actin polymerization and a-actinin which
plays an important role in actin-membrane interactions [376—
378]. Additionally, activation of calpains could affect interac-
tions among actin and the many other proteins linking it to the
plasma membrane; integral membrane proteins such as uvo-
morulin and the laminin and fibronectin receptors [377, 379],
membrane associated proteins such as ankyrin, fodrin, a-acti-
nm, vinculin, and the 110 kd microvillus protein [377, 3791, and
cross linking proteins such as villin and fimbrin [3801.
3) Membrane phospholipids interact with and regulate the
function of cytoskeletal proteins. Specific interactions of this
type include preferential binding of diacylglycerol and palmitic
acid to a-actinin [377] and regulation by phosphatidylinositol
bisphosphate of gelsolin and profilin activity [381, 382]. Lipid
interactions with other membrane associated proteins such as
spectrin, vinculin, and protein 4.1 as well as with intermediate
filaments and microtubules [377] and myosin [3831 have also
been described. Additionally, cytoskeletal proteins can be
covalently linked to fatty acids, a posttranslational modification
which could occur directly at the membrane. There is good
evidence for covalent linkage of fatty acids to ankyrin, vinculin
and protein 4.1 [3771.
4) Actions of oxidants to cross link actin and actin-binding
protein and deplete cytoskeleton protein thiols have been
described [384, 385].
There is relatively little information about specific manifes-
tations of these processes during injury. The potential for their
interactions is illustrated by a recent study of cytoskeletal
changes in platelets treated with menadione, a redox-active
quinone which produces oxidant injury to hepatocytes [385].
Multiple cytoskeletal abnormalities were found: proteolysis of
actin binding protein by Ca2-activated proteases, direct effects
of increased cytosolic Ca2 to dissociate actin, c-actinin and
actin binding protein from the Triton X- 100-insoluble cytoskel-
eton, and oxidative modification of actin and crosslinking of
actin, a-actinin and actin binding protein.
A common pattern of microfilament alterations has been
described during ATP depletion induced by metabolic inhibitors
in cultured fibroblasts [369], epithelial cells [386], and endothe-
hal cells [387, 3881. This pattern consisted of disassembly and
shortening of stress fibers with retraction from the membrane
and appearance of side-side aggregates by electron microscopy.
In all these systems the changes were rapidly reversed during
recovery from the metabolic inhibitor and were not associated
with loss of cell viability or adherence.
The cell injury manifestation most commonly taken to indi-
cate disturbance of the cytoskeleton is the blebbing seen during
both ischemic and toxic injury in a variety of cell types [50, 210,
212, 389—3911. Although clearly involving a significant distur-
bance of the cytoskeleton and cytoskeleton-membrane interac-
tions [3921, the precise pathophysiology of blebbing remains
incompletely defined.
In primary cultures of rabbit proximal tubule cells treated
with a variety of toxins and metabolic inhibitors, cytosohic Ca2
increased and the degree and duration of the Ca2 increase
correlated closely with both the extent of blebbing and the
rapidity of development of cell death [2101, implying a causal
relationship between Ca2 and blebbing via one or more of the
mechanisms detailed above. This contrasts with results in
primary cultures of isolated hepatocytes where blebbing was
not preceded by elevations of cytosolic Ca2 [212, 213]. In that
system, cell death appeared to be precipitated abruptly by
rupture of the plasma membrane in an area of a large or
particularly unstable bleb [212, 213]. An important role for this
type of membrane instability in areas weakened by blebs has
also been suggested in myocardial ischemia where plasma-
lemma fragmentation was observed primarily in areas of the
sarcolemma overlying blebs [393] and was accelerated by
osmotic swelling conditions that did not damage oxygenated
cells [394, 395]. Anoxic damage was accompanied by loss of
vincuhin and subplasmalemma microfilament structures [393,
396].
Major structural rearrangements likely involving the cy-
toskeleton occur in ischemic tubule cells. The proximal tubule
brush border membrane is prominently affected. Ischemia
durations as short as five minutes produce coalescence and
interiorization of a majority of the microvilli. Some microvilhi
are shed into the lumen, although luminal obstruction does not
occur [50, 390]. Reoxygenation allows recovery of apparently
normal morphology within several hours due to recycling of the
interiorized membranes [397]. With longer durations of isch-
emia (60 mm), much more shedding of membranes with exten-
sive obstruction distally secondary to impaction of tubule
lumens with blebs is seen [50].
Recent observations have indicated that these morphological
alterations may also be accompanied by significant loss of
functional polarity which is sustained for prolonged periods
even after apparently normal structure has been reestablished.
Brush border membranes isolated from ischemic kidneys were
normally enriched in brush border enzyme markers, but also
showed enrichment of Na-K-ATPase and decreases of the
normally high sphingomyehin levels and sphingomyelin/phos-
phatidylchohine ratios seen in brush border membranes as
compared to basolateral membranes [398, 399]. Na-K-ATPase
was also found in apical regions in situ by cytochemical
methods 11398]. The redistribution of Na-K-ATPase was cone-
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lated with increased permeability of tight junctions as measured
by penetration of microinfused ruthenium red [400]. Taken
together, these observations imply a major loss of integrity of
the epithelial junctional complex, particularly of ihe zonula
adherens which appears to be most responsible for maintaining
its structure [3791. Which components of the zonula adherens
are most importantly involved remains to be determined. The
changes of enzyme distribution, as well as changes of enzyme
activity related to alterations of phospholipid content [4011
could contribute to delayed functional recovery of tubules that
otherwise are viable [398, 402].
MDCK cells treated with H202 showed increases of trans-
epithelial conductance and permeability to mannitol, pulling
apart of neighboring cells, fragmentation of cytoplasmic stain-
ing for F-actin, and thinning and beading of F-actin staining at
cell-cell junctions [403]. Disruption of the cytoskeleton also
clearly has the potential to impair cell adhesion to the basement
membrane [404]. Loss of otherwise viable cells from the tubule
epithelium could contribute just as much to backleak as necro-
sis of those cells. The relevance of this process to acute renal
failure in vivo is supported by the finding that urine from
patients with acute renal failure contain greatly increased
numbers of tubule cells, of which a surprisingly large fraction
are viable based on morphologic criteria and ability to be placed
into tissue culture [405].
At present, information on the behavior of specific cytoskel-
etal components in common models of ischemic renal injury is
limited. In a preliminary report, five minutes of ischemia
produced gaps in the terminal web underlying the renal brush
border membrane which became much larger at 15 minutes. By
50 minutes actin was redistributed throughout the cytoplasm.
Cytocholasin D induced patchy desruption of the brush border
and decreased fractional Na reabsorption of the isolated
perfused kidney [4061. However, treatment of LLC-PK1 cells
with cytochalasin D increased their resistance to anoxic injury
even though it enhanced ATP depletion [407]. Further studies
will be needed to clarify the role of cytosokeletal changes in
maintenance of cell viability and overall structure during isch-
ernie injury in the kidney, but they are likely to yield results
important for understanding the pathogenesis of ischemic dam-
age.
Several morphologic patterns of advanced tubule cell injury
have been described in both experimental models and human
acute renal failure. In addition to cells which exhibit the
swelling, decreased cytoplasmic density and general fragmen-
tation characteristic of acute lethal cell injury, shrunken-ap-
pearing cells with marked cytoplasmic and nuclear condensa-
tion are frequently observed [20, 24, 25, 27, 47, 54, 390, 408,
409]. Whether these changes indicate fundamentally different
mechanisms of progression to lethal cell injury or different
timing of the lesions and whether they are are primarily related
to differences in cytoskeletal injury, membrane water perme-
ability or other cytosolic components remains to be clarified.
Heat shock proteins
Brief exposure to heat or a variety of other non-lethal stresses
induces production of a group of closely related proteins,
usually termed "heat shock proteins", in virtually all species.
Concomitantly there is a generalized inhibition of synthesis of
other proteins. The response is associated with enhanced
tolerance to a second insult [410]. Although attention has
focused on the most prominent heat shock proteins falling into
three size classes, 70, 83 to 90 and 20 to 30 kd, heat shock
proteins number in the dozens and, even the major size classes
consist of families of proteins [410—412]. Additionally, a related
and interacting, but distinct stress response is seen during
conditions of glucose deprivation [412]. Despite much work,
full functional characterization of even the major heat shock
proteins remains incomplete. However, most data indicate
involvement of heat shock proteins in regulation of cell protein
metabolism to control degradation of damaged proteins [350,
4101 and regulate synthesis of new proteins [411, 413] during
adverse conditions or recovery. Interactions with the cytoskel-
eton [410, 4141 and regulation by Ca2*caimodulin [414] have
been reported, thus further linking these proteins to structures
and cellular mediators involved in the injury process.
Ischemia, anoxia, and ATP-depleting metabolic inhibitors
have been shown to induce the heat shock response in various
cell types [410, 412, 415, 416]. Induction of the heat shock
response with hyperthermia has been reported to ameliorate
subsequent ischemic injury in the heart [417]. As yet, there is no
published information on the role of the heat shock response of
the kidney during renal ischemia, however this is a potentially
fruitful, albeit complex, area for research.
Enhanced resistance by the kidney to second insults has been
found after heavy metal- and glycerol-induced nephrotoxicity
[4181, and heavy metals can induce heat shock proteins [419],
but direct relationships in the kidney remain to be studied. The
pattern of response to second insults is more variable in
ischemia models [420, 4211. Interpretation of the available data
on altered renal susceptibility to second insults is complex
because of the potential for altered hemodynamics and solute
delivery patterns [418]. Additionally, at the cellular level,
recovering cells with decreased surface area and transport
capacity [422] as well as different patterns of metabolism (such
as, enhanced glycolysis [45, 423]), may have altered suscepti-
bility on the basis of these effects, rather than due to heat shock
protein-related phenomena. Induction of metallothionein will
contribute to increased resistance to heavy metals [32, 424].
Special considerations pertaining to expression of acute
ischemic cell damage within the kidney in vivo
Ischemic acute renal failure in vivo is characterized by the
appearance of advanced tubule cell injury during a period of
hours after reperfusion, rather than during ischemia itself [24,
25, 27, 50—52]. Oxidant damage would be expected to be most
prominent with reflow and could contribute to the expression of
injury at that time. Many of the other factors already reviewed
in detail may also contribute to this phenomenon.
Although decreases of whole renal blood flow do not appear
to account for the functional abnormalities of ischemic acute
renal failure [425—428], the fact that damage during reflow is
greatest in the outer medulla areas [24, 25, 27, 50—52], which are
most marginally perfused [6, 7] and in which erythrocyte
trapping is prominent [164, 166, 344, 429], supports the concept
that failure of reflow at the microvascular level results in
continuing oxygen deprivation at a time when tubules are
partially damaged, but are resuming transport function and
consuming ATP for that purpose. This would subject them to a
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continuing ATP depletion-induced insult and is most consistent
with the observation that isolated tubules sustain most of their
injury during oxygen deprivation, not during reoxygenation,
and that treatment with atrial natriuretic peptide immediately
after ischemia can markedly alleviate the structural and func-
tional damage [327, 328].
During ischemia, the tissue Ca2 pool is limited to what is
already in the intracellular space. Reperfusion would deliver a
sustained heavy Ca2 load which could overload the buffering
and extrusion capacities of damaged cells. Along the same
lines, reperfusion could introduce a volume stress on cells by
delivery of increased fluid and initiation of transcellular solute
transport. The likelihood of these mechanisms is subject to the
same considerations which have been detailed relative to their
role during ischemia.
In view of the data from isolated tubule studies on the
protective effects of reduced pH, it is conceivable that the
normalization of tissue pH promotes damage during reflow,
particularly if it occurs in a setting where cells are already
damaged and not fully reoxygenated. Evidence for reperfusion
damage to the liver related to normalization of pH has been
reported [430]. The recent observations about importance of
glycine and alanine in tubule resistance to oxygen deprivation-
induced damage [22, 23, 140, 261] raise the possibility that
washout of these amino acids could contribute to reflow damage
if circulating levels are not adequate for rapid replacement.
Regeneration of ATP could be transiently damaging to in-
jured tubules. As noted previously, depolymerization of actin is
ATP dependent and the cytoskeleton-disrupting effects of cy-
tochalasin are delayed in metabolic inhibitor-treated cells [369,
387]. Some proteases are ATP dependent [350]. Although the
contribution of oxidant injury was not critically assessed, it is of
interest that cellular disruption which occurred on reoxygen-
ation of hypoxic hearts was reduced by preventing the resump-
tion of mitochondrial phosphorylation with either cyanide [4311
or an uncoupler [432], an effect that was attributed to preven-
tion of uncontrolled contracture produced by ATP repletion
[432].
At present, which if any of these factors is most important is
unknown, however, a recent study using hypothermia to pre-
vent injury in vivo is informative as to the timing of the critical
event. Consistent with earlier work on the importance of
temperature in determining the time course of renal ischemic
injury [19, 433], induction of hypothermia during ischemia and
the first 30 minutes of reflow provided virtually complete
protection against structural and functional damage expressed
at 24 hours [4341. Most of this protection could also be achieved
by limiting hypothermia to just the period of ischemia. In
contrast, limiting hypothermia to the first 30 minutes of reper-
fusion provided a small amount of protection. Introducing
hypothermia after 30 minutes provided no protection. Thus, the
ischemic period itself is most important for determining the
ultimate cellular outcome, even though the outcome is not fully
evident for a number of hours. However, the fact that atrial
natriuretic peptide provides major protection when adminis-
tered only during reflow [327, 328] suggests that the late damage
requires both changes induced during ischemic and subsequent
events.
Most of the information available to review about the cell
biology of renal ischemic injury concerns tubule cell damage,
since that is prominently expressed in all animal models and is
amenable to study by a variety of approaches. Morphologic
studies of human biopsy material have indicated that similar
types of tubule cell damage are present during both ischemic
injury to native kidneys and to transplanted kidneys, but that
the quantitative distribution of types of lesions differs from the
animal models. In man, lethal tubule cell injury is much less
extensive, but there are widespread alterations of normal cell
architecture with loss of both apical and basolateral surface
area [408, 409, 422, 435]. What accounts for these differences
and how the consequences of tubular damage [4361 and sus-
tained vascular abnormalities interact in the human syndrome
remain incompletely defined because of the difficulties studying
them. However, there is no reason to expect that the basic cell
biology of ischemic injury will be fundamentally different
except in availability and relative importance of particular
biochemical processes that should ultimately be definable.
The repair process
The most common forms of ischemic acute renal failure are
reversible. They do not produce diffuse cortical necrosis going
onto permanent obliteration of all structures, but rather involve
sufficiently selective tubular injury to allow repair of the dam-
aged epithelium and recovery of normal structure and function.
Even completely reversible insults, as discussed previously
with regard to brush border alterations, can be characterized by
major tubule cell structural changes which must be repaired.
Lethally injured cells must be replaced.
Infusions of amino acid mixtures have been reported to
enhance phosphatidylcholine and protein synthesis and to de-
crease protein degradation in a nephrotoxic model of acute
renal failure [437], suggesting a favorable influence on repair or
regeneration processes. Accelerated turnover of tubule cells
has been reported as a very early manifestation of aminoglyco-
side nephrotoxicity [438]. Thyroid hormone, a required constit-
uent of serum-free media supporting tubule cell proliferation in
vitro, had beneficial effects on nephrotoxic and ischemic acute
renal failure [439-441]. Actions of growth factors including
epidermal growth factor (EGF) [442], transforming growth
factor-a [443], transforming growth factor-a [442] and insulin-
like growth factor [444] on cultured tubule epithelial cells have
been described. Studies have shown that EGF receptor number
increases while renal EGF production apparently decreases
after ischemic acute renal failure [4451, and have suggested that
administration of EGF after the ischemic insult enhances re-
covery in association with acceleration of tubule cell prolifera-
tion [446, 447]. Tubule cells [442, 444, 448—451], endothelial
cells [448, 4521 and infiltrating inflammatory cells [453, 454] are
all potential sources of growth regulating polypeptides. Adenine
nucleotides and adenosine released from damaged cells may
also act via surface receptors linked to phospholipase C and
adenylate cyclase [111] to influence proliferation [455—4601. The
peptide growth factors and purines also can influence fibroblast
proliferation [105, 458, 461—465] as well as matrix production by
fibroblasts and epithelial cells, thus contributing to chronic
interstitial changes.
Detailed consideration of the various interactions among
these systems is beyond the scope of this review and there is
presently relatively little data on their specific behavior during
ischemic acute renal failure. However, this area of study is
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receiving increasing interest and should contribute much to
understanding the cell biology of ischemic acute renal failure in
the future.
Conclusions
The past several years has seen substantial progress in
understanding roles of major events such as alterations of
cellular purines and calcium metabolism and generation of
reactive oxygen metabolites in the pathogenesis of ischemic and
post-ischemic tubular cell injury. The critical cellular targets for
these events remain incompletely defined and will require
continued studies with modern cell biology techniques. Avail-
ability of potent maneuvers for interrupting ischemic injury in
some systems such as reduced pH and glycine should greatly
help in determining the priority of various pathogenetic pro-
cesses.
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